Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Designing an Informatics Infrastructure for a National Aged Care Medication Roundtable.

Studies in health technology and informatics·2024
Same author

Stakeholder perspectives of a pilot multicomponent delirium prevention intervention for adult patients with advanced cancer in palliative care units: A behaviour change theory-based qualitative study.

Palliative medicine·2022
Same author

Development and dissemination of the national strategic action plan for reducing inappropriate polypharmacy in older Australians.

Internal medicine journal·2021
Same author

Sensorimotor, Cognitive, and Affective Functions Contribute to the Prediction of Falls in Old Age and Neurologic Disorders: An Observational Study.

Archives of physical medicine and rehabilitation·2020
Same author

A comparison of machine learning methods for survival analysis of high-dimensional clinical data for dementia prediction.

Scientific reports·2020
Same author

Does Antihypertensive Use Moderate the Effect of Blood Pressure on Cognitive Decline in Older People?

The journals of gerontology. Series A, Biological sciences and medical sciences·2020

Related Experiment Video

Updated: Jun 9, 2026

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

Dementia services in Australia.

Henry Brodaty1, Anne Cumming

  • 1School of Psychiatry, University of New South Wales, Sydney, NSW, Australia. h.brodaty@unsw.edu.au

International Journal of Geriatric Psychiatry
|August 31, 2010
PubMed
Summary
This summary is machine-generated.

Australian dementia services are expanding to meet a projected increase in cases by 2050. While care is developing, enhanced support for carers and specific populations, alongside increased research funding, is needed.

More Related Videos

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

Related Experiment Videos

Last Updated: Jun 9, 2026

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

Area of Science:

  • Gerontology
  • Public Health Policy
  • Neuroscience

Background:

  • The prevalence of dementia in Australia is significant, with projections indicating a substantial rise.
  • Current estimates place the number of Australians with dementia at 220,000, projected to reach 1.13 million by 2050.

Purpose of the Study:

  • To provide a comprehensive overview of dementia services currently available in Australia.
  • To identify areas for improvement and future development in dementia care.

Main Methods:

  • A review of existing Australian government policies related to dementia care.
  • Analysis of relevant academic and research papers on dementia services.

Main Results:

  • Australian governments have implemented extensive plans for dementia care, including community and residential services.
  • Initiatives focus on improving care quality, addressing behavioral symptoms, and expanding community support packages.
  • Alzheimer's Australia plays a key role in advocacy and has developed dementia prevention programs.

Conclusions:

  • Dementia care in Australia is robust but requires further development.
  • Key areas for enhancement include public awareness, stigma reduction, carer support, and timely diagnosis.
  • Special attention is needed for Indigenous and non-English speaking communities, younger onset dementia, and dementia research funding.